Certara Inc (CERT) News

Form 8-K - Current report

Form 8-K - Current report

Certara to Acquire Chemaxon to Strengthen Drug Discovery Software Portfolio

Combined organization brings broader predictive capabilities to drug discovery at scale Reiterates full year...

Certara to Report Second Quarter 2024 Financial Results on August 6th, 2024

RADNOR, Pa., July 02, 2024 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in...

Certara Launches Next Generation CoAuthor™ Generative AI Regulatory Writing Software

RADNOR, Pa., June 17, 2024 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in...

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form 3 - Initial statement of beneficial ownership of securities

Form 3 - Initial statement of beneficial ownership of securities

Certara to Participate in the Jefferies Global Healthcare Conference

RADNOR, Pa., May 29, 2024 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in biosimulation...

Form 8-K - Current report

Certara Appoints New Chief Human Resources Officer & General Counsel

RADNOR, Pa., May 21, 2024 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in model-informed...

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Form 8-K - Current report

Certara Reports First Quarter 2024 Financial Results

PRINCETON, N.J., May 07, 2024 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in...